Mark Edelstein
-
- Acute Myeloid Leukemia Research 2
-
- Chronic Lymphocytic Leukemia Research 3
-
- Acute Lymphoblastic Leukemia research 4
-
- DNA Repair Mechanisms 3
- Biochemical and Molecular Research 3
- Cancer therapeutics and mechanisms 3
-
- Ovarian cancer diagnosis and treatment 3
-
- Effects of Radiation Exposure 3
- Co-authors
- Teresa J. ViettiFred ValerioteFrederick A. ValerioteL. M. van PuttenHeinz H. FiebigThomas H. CorbettMichael BischoffLaurence H. Baker
- Cited by
- HematologyCancer ResearchGenetics
- Journals
- JNCI Journal of the National Cancer Institute (2 papers)Cancer Investigation (2 papers)Investigational New Drugs (1 paper)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Mark Edelstein
26 papers receiving 289 citations
Peers
Comparison fields: 5 of 55
- Hematology 55
- Cancer Research 55
- Genetics 38
- Oncology 88
- Pathology and Forensic Medicine 41
Countries citing papers authored by Mark Edelstein
This map shows the geographic impact of Mark Edelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Edelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Edelstein more than expected).
Fields of papers citing papers by Mark Edelstein
This network shows the impact of papers produced by Mark Edelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Edelstein. The network helps show where Mark Edelstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Edelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 47 | |
| 2 | 1998 | 1 | |
| 3 | 1998 | 2 | |
| 4 | 1997 | 24 | |
| 5 | 1996 | 21 | |
| 6 | Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis. | 1996 | 1 |
| 7 | 1990 | 3 | |
| 8 | 1989 | 5 | |
| 9 | In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells. | 1989 | 23 |
| 10 | Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice. | 1988 | 4 |
| 11 | 1984 | 21 | |
| 12 | In vivo studies on the regeneration kinetics of haemopoietic spleen colony-forming cells from long-term bone marrow cultures. | 1983 | 1 |
| 13 | 1983 | 36 | |
| 14 | 1983 | 8 | |
| 15 | 1980 | 1 | |
| 16 | Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia. | 1978 | 2 |
| 17 | 1978 | 7 | |
| 18 | 1977 | 2 | |
| 19 | 1977 | 21 | |
| 20 | The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate. | 1975 | 28 |
About Mark Edelstein
Mark Edelstein is a scholar working on Hematology, Genetics, Reproductive Medicine, Cancer Research and Oncology, having authored 27 papers that have together received 321 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), DNA Repair Mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Biochemical and Molecular Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Effects of Radiation Exposure (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (55 citations), Cancer Research (55 citations), Genetics (38 citations), Oncology (88 citations) and Pathology and Forensic Medicine (41 citations). Mark Edelstein has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Teresa J. Vietti, Fred Valeriote, Frederick A. Valeriote, L. M. van Putten, Heinz H. Fiebig, Thomas H. Corbett, Michael Bischoff, Laurence H. Baker, E. A. de Bruijn and Uwe Reichert. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer Investigation, Investigational New Drugs, Recent results in cancer research and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.